Krebs Biochem

{
  "main_header": {
    "sid": 142337,
    "name": "Krebs Biochem",
    "stock_name": "Krebs Biochem",
    "full_name": "Krebs Biochemicals & Industries Ltd",
    "name_url": "stocks-analysis/krebs-biochem",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "58.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "58.00",
    "mcapval": "125.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524518,
    "symbol": "KREBSBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE268B01013",
    "curr_date": "Feb 02",
    "curr_time": "",
    "bse_nse_vol": "803 ",
    "exc_status": "Active",
    "traded_date": "Feb 02, 2026",
    "traded_date_str": "2026 02 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/krebs-biochem-142337-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-3807309",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KrebsBiochemica_mojoScore_3807309.png",
        "date": "2026-01-28 10:10:35",
        "description": "Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 January 2026, providing investors with the most recent and relevant data to assess the stock’s outlook."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd Falls to 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krebs-biochemicals-industries-ltd-falls-to-52-week-low-amidst-continued-downtrend-3805909",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KrebsBiochemica_priceRelatedfactors_3805909.png",
        "date": "2026-01-27 11:02:59",
        "description": "Krebs Biochemicals & Industries Ltd has reached a new 52-week low, reflecting ongoing pressures on the stock amid a challenging market environment and subdued company performance. The stock's latest decline to this significant price level underscores persistent headwinds within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krebs-biochemicals-industries-ltd-hits-52-week-low-amidst-continued-downtrend-3796723",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KrebsBiochemica_priceRelatedfactors_3796723.png",
        "date": "2026-01-20 15:10:34",
        "description": "Krebs Biochemicals & Industries Ltd has touched a new 52-week low of Rs.60.17 today, marking a significant decline in its stock price amid broader market pressures and company-specific performance issues."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd Hits 52-Week Low Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krebs-biochemicals-industries-ltd-hits-52-week-low-amidst-continued-downtrend-3791205",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KrebsBiochemica_priceRelatedfactors_3791205.png",
        "date": "2026-01-12 13:43:05",
        "description": "Krebs Biochemicals & Industries Ltd has reached a new 52-week low, reflecting ongoing pressures on the stock amid subdued financial performance and sector underperformance. The stock’s latest decline to this significant price level underscores persistent challenges faced by the company in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-3781580",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/KrebsBiochemica_mojoScore_3781580.png",
        "date": "2026-01-05 10:11:38",
        "description": "Krebs Biochemicals & Industries Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 January 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-3769220",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KrebsBiochemica_mojoScore_3769220.png",
        "date": "2025-12-25 12:57:37",
        "description": "Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Why is Krebs Biochem falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-krebs-biochem-fallingrising-3757748",
        "imagepath": "",
        "date": "2025-12-13 01:05:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>The stock’s recent performance has outpaced its sector by 0.41% on the day, and it has delivered a 5.43% return over the past four trading sessions. This upward trend contrasts with the broader market, where the Sensex declined by 0.52% over the last week. Over the past month, Krebs Biochemicals has gained 5.13%, significantly outperforming the Sensex’s 0.95% rise. These figures suggest that investors are showing renewed interest in the stock in the near term, possibly driven by technical factors or short-term trading strategies.</p>\n<p>However, the stock remains below its longer-term moving averages, including the 50-day, 100-day, and 200-day averages, indicating that the broader trend remains subdued. The stock’s liquidity is ade..."
      },
      {
        "title": "Krebs Biochem Sees Revision in Market Evaluation Amid Challenging Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krebs-biochem-downgraded-to-strong-sell-amid-deteriorating-fundamentals-3748212",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/KrebsBiochem_mojoScore_3748212.png",
        "date": "2025-12-05 10:10:27",
        "description": "Krebs Biochem, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a notable revision in its market evaluation. This shift reflects recent changes in the company’s fundamental and technical outlook, highlighting ongoing challenges in its financial performance and market positioning."
      },
      {
        "title": "Why is Krebs Biochem falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-krebs-biochem-fallingrising-3693428",
        "imagepath": "",
        "date": "2025-11-12 22:09:28",
        "description": "As of 12-Nov, Krebs Biochemicals & Industries Ltd is experiencing a decline in its stock price, currently at Rs 66.89, which reflects a decrease of Rs 3.05 or 4.36%. The stock has underperformed significantly today, with a performance that is 5.34% lower than its sector. It opened with a loss of 2.77% and reached an intraday low of Rs 66.89. Additionally, the stock is trading below all key moving averages, indicating a bearish trend. Over the past week, the stock has fallen by 5.51%, and its year-to-date performance shows a substantial decline of 27.69%. Notably, investor participation has dropped sharply, with delivery volume plummeting by 92.31% compared to the five-day average, suggesting a lack of confidence among investors.\n\nIn the broader market context, Krebs Biochem's performance contrasts sharply with the Sensex, which has gained 1.21% over the past week and 8.10% year-to-date. This divergence indi..."
      }
    ],
    "total": 118,
    "sid": "142337",
    "stock_news_url": "https://www.marketsmojo.com/news/krebs-biochemicals-industries-142337"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Board Meeting Intimation To Consider And Adopt The Unaudited Financial Results For The 3Rd Quarter And Nine Months Ended December 31 2025",
      "datetime": "14-Jan-2026",
      "details": "Krebs Biochemicals & Industries Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 inter alia to consider and approve Board Meeting intimation to consider and adopt the unaudited financial results for the 3rd quarter and nine months ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "Report On Re-Lodgement Of Transfer Requests Of Physical Shares Dec 2025",
      "datetime": "05-Jan-2026",
      "details": "The Company has enclosed herewith report on relodgement of shares for the month of December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "02-Jan-2026",
      "details": "The Company has enclosing herewith certificate recived from RTA under Regulation 74(5) of SEBI (DP) Regulations 2018 for the quarter ended 31.12.2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "09 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Krebs Biochemicals & Industries Ltd has announced <strong>21:100</strong> rights issue, ex-date: 31 Jan 19",
          "dt": "2019-01-31",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Krebs Biochemicals & Industries Ltd is Rated Strong Sell

2026-01-28 10:10:35

Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 28 January 2026, providing investors with the most recent and relevant data to assess the stock’s outlook.

Read full news article

Krebs Biochemicals & Industries Ltd Falls to 52-Week Low Amidst Continued Downtrend

2026-01-27 11:02:59

Krebs Biochemicals & Industries Ltd has reached a new 52-week low, reflecting ongoing pressures on the stock amid a challenging market environment and subdued company performance. The stock's latest decline to this significant price level underscores persistent headwinds within the Pharmaceuticals & Biotechnology sector.

Read full news article

Krebs Biochemicals & Industries Ltd Hits 52-Week Low Amidst Continued Downtrend

2026-01-20 15:10:34

Krebs Biochemicals & Industries Ltd has touched a new 52-week low of Rs.60.17 today, marking a significant decline in its stock price amid broader market pressures and company-specific performance issues.

Read full news article

Krebs Biochemicals & Industries Ltd Hits 52-Week Low Amidst Continued Downtrend

2026-01-12 13:43:05

Krebs Biochemicals & Industries Ltd has reached a new 52-week low, reflecting ongoing pressures on the stock amid subdued financial performance and sector underperformance. The stock’s latest decline to this significant price level underscores persistent challenges faced by the company in the Pharmaceuticals & Biotechnology sector.

Read full news article

Krebs Biochemicals & Industries Ltd is Rated Strong Sell

2026-01-05 10:11:38

Krebs Biochemicals & Industries Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 05 January 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Krebs Biochemicals & Industries Ltd is Rated Strong Sell

2025-12-25 12:57:37

Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 25 December 2025, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Why is Krebs Biochem falling/rising?

2025-12-13 01:05:08

Short-Term Price Movement and Market Context

The stock’s recent performance has outpaced its sector by 0.41% on the day, and it has delivered a 5.43% return over the past four trading sessions. This upward trend contrasts with the broader market, where the Sensex declined by 0.52% over the last week. Over the past month, Krebs Biochemicals has gained 5.13%, significantly outperforming the Sensex’s 0.95% rise. These figures suggest that investors are showing renewed interest in the stock in the near term, possibly driven by technical factors or short-term trading strategies.

However, the stock remains below its longer-term moving averages, including the 50-day, 100-day, and 200-day averages, indicating that the broader trend remains subdued. The stock’s liquidity is ade...

Read full news article

Krebs Biochem Sees Revision in Market Evaluation Amid Challenging Fundamentals

2025-12-05 10:10:27

Krebs Biochem, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a notable revision in its market evaluation. This shift reflects recent changes in the company’s fundamental and technical outlook, highlighting ongoing challenges in its financial performance and market positioning.

Read full news article

Why is Krebs Biochem falling/rising?

2025-11-12 22:09:28

As of 12-Nov, Krebs Biochemicals & Industries Ltd is experiencing a decline in its stock price, currently at Rs 66.89, which reflects a decrease of Rs 3.05 or 4.36%. The stock has underperformed significantly today, with a performance that is 5.34% lower than its sector. It opened with a loss of 2.77% and reached an intraday low of Rs 66.89. Additionally, the stock is trading below all key moving averages, indicating a bearish trend. Over the past week, the stock has fallen by 5.51%, and its year-to-date performance shows a substantial decline of 27.69%. Notably, investor participation has dropped sharply, with delivery volume plummeting by 92.31% compared to the five-day average, suggesting a lack of confidence among investors. In the broader market context, Krebs Biochem's performance contrasts sharply with the Sensex, which has gained 1.21% over the past week and 8.10% year-to-date. This divergence indi...

Read full news article

View All News